Stock listing
NASDAQ:NCEL NewcelX Ltd. Stock
Home listing (NASDAQ) of NewcelX Ltd.
Follow NewcelX Ltd. into a list and get an email when it puts out news.
Share price · NASDAQ:NCEL
$2.55 USD -0.14 (-5.3%)
Close on Oct 30, 2026
- Day range
- $2.50 – $2.75 USDOct 30, 2026
- Volume
- 11,157 sharesOct 30, 2026
- Market cap
- $14.73M USDAt the close on Oct 30, 2026 · price × 5.78M shares outstanding
- 52-week range
- $1.83 – $7.64 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $26,860 USDMedian day 6,450 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:NCEL · Home | $2.55 USD | -0.142 (-5.3%) | 11,157 | $2.59 | $2.75 | $2.50 | $2.692 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:NCEL · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $2.55 | -0.142 | -5.3% | $2.59 | $2.75 | $2.50 | 11,157 | |
| $2.692 | -0.008 | -0.3% | $2.70 | $2.73 | $2.648 | 1,701 | |
| $2.70 | -0.04 | -1.5% | $2.72 | $2.80 | $2.61 | 3,864 | |
| $2.74 | +0.19 | +7.5% | $2.59 | $2.80 | $2.59 | 12,390 | |
| $2.55 | -0.11 | -4.1% | $2.49 | $2.84 | $2.44 | 16,190 | |
| $2.66 | +0.10 | +3.9% | $2.53 | $2.76 | $2.49 | 10,400 | |
| $2.56 | -0.39 | -13.2% | $2.97 | $3.00 | $2.36 | 12,200 | |
| $2.95 | +0.34 | +13.0% | $2.59 | $3.04 | $2.59 | 11,900 | |
| $2.61 | -0.02 | -0.8% | $2.72 | $3.00 | $2.55 | 9,400 | |
| $2.63 | +0.13 | +5.2% | $2.90 | $2.90 | $2.53 | 5,400 | |
| $2.50 | -0.35 | -12.3% | $2.77 | $3.14 | $2.361 | 23,100 | |
| $2.85 | +0.24 | +9.2% | $2.61 | $2.90 | $2.61 | 5,900 | |
| $2.61 | -0.23 | -8.1% | $2.80 | $2.87 | $2.61 | 9,300 | |
| $2.84 | -0.064 | -2.2% | $2.83 | $3.279 | $2.80 | 5,400 | |
| $2.904 | -0.141 | -4.6% | $2.96 | $2.96 | $2.904 | 1,200 | |
| $3.045 | -0.065 | -2.1% | $3.02 | $3.082 | $3.02 | 1,300 | |
| $3.11 | +0.075 | +2.5% | $2.925 | $3.11 | $2.89 | 7,300 | |
| $3.035 | +0.074 | +2.5% | $3.04 | $3.04 | $2.975 | 1,500 | |
| $2.961 | +0.101 | +3.5% | $2.99 | $3.20 | $2.916 | 7,200 | |
| $2.86 | +0.01 | +0.4% | $2.824 | $2.86 | $2.82 | 4,100 | |
| $2.85 | -0.06 | -2.1% | $2.83 | $2.871 | $2.791 | 3,000 | |
| $2.91 | -0.165 | -5.4% | $2.82 | $2.95 | $2.76 | 5,200 | |
| $3.075 | +0.105 | +3.5% | $3.22 | $3.25 | $3.00 | 2,700 | |
| $2.97 | +0.05 | +1.7% | $2.85 | $2.97 | $2.79 | 3,100 | |
| $2.92 | -0.027 | -0.9% | $2.87 | $3.02 | $2.76 | 7,200 | |
| $2.947 | +0.057 | +2.0% | $2.99 | $3.21 | $2.947 | 4,800 | |
| $2.89 | +0.03 | +1.0% | $2.89 | $2.90 | $2.76 | 4,200 | |
| $2.86 | -0.176 | -5.8% | $2.91 | $3.09 | $2.758 | 9,300 | |
| $3.036 | +0.066 | +2.2% | $2.96 | $3.37 | $2.90 | 4,700 | |
| $2.97 | -0.18 | -5.7% | $3.23 | $3.243 | $2.90 | 12,300 | |
| $3.15 | -0.23 | -6.8% | $3.158 | $3.38 | $3.13 | 2,500 | |
| $3.38 | -0.01 | -0.3% | $3.295 | $3.39 | $3.15 | 12,200 | |
| $3.39 | +0.07 | +2.1% | $3.293 | $3.40 | $3.14 | 4,600 | |
| $3.32 | +0.04 | +1.2% | $3.35 | $3.35 | $3.31 | 2,800 | |
| $3.28 | -0.025 | -0.8% | $3.28 | $3.31 | $3.225 | 6,800 | |
| $3.305 | -0.075 | -2.2% | $3.30 | $3.324 | $3.224 | 3,700 | |
| $3.38 | +0.13 | +4.0% | $3.29 | $3.50 | $3.25 | 5,700 | |
| $3.25 | 0.00 | 0.0% | $3.16 | $3.30 | $3.16 | 3,500 | |
| $3.25 | -0.10 | -3.0% | $3.235 | $3.35 | $3.22 | 4,200 | |
| $3.35 | 0.00 | 0.0% | $3.37 | $3.37 | $3.24 | 1,400 | |
| $3.35 | 0.00 | 0.0% | $3.458 | $3.50 | $3.147 | 9,000 | |
| $3.35 | +0.06 | +1.8% | $3.39 | $3.39 | $3.33 | 3,500 | |
| $3.29 | +0.015 | +0.5% | $3.21 | $3.29 | $3.21 | 1,900 | |
| $3.275 | +0.085 | +2.7% | $3.40 | $3.40 | $3.23 | 13,900 | |
| $3.19 | -0.23 | -6.7% | $3.37 | $3.37 | $3.19 | 12,400 | |
| $3.42 | +0.04 | +1.2% | $3.27 | $3.51 | $3.27 | 20,000 | |
| $3.38 | -0.10 | -2.9% | $3.44 | $3.514 | $3.30 | 18,700 | |
| $3.48 | +0.02 | +0.6% | $3.50 | $3.60 | $3.31 | 17,000 | |
| $3.46 | +0.197 | +6.0% | $3.40 | $3.50 | $3.325 | 6,100 | |
| $3.263 | -0.107 | -3.2% | $3.31 | $3.31 | $3.215 | 1,400 | |
| $3.37 | +0.12 | +3.7% | $3.25 | $3.40 | $3.17 | 9,200 | |
| $3.25 | -0.14 | -4.1% | $3.39 | $3.39 | $3.167 | 14,500 | |
| $3.39 | +0.13 | +4.0% | $3.19 | $3.40 | $3.19 | 7,300 | |
| $3.26 | -0.085 | -2.5% | $3.33 | $3.50 | $3.25 | 5,400 | |
| $3.345 | -0.255 | -7.1% | $3.46 | $3.46 | $3.11 | 46,800 | |
| $3.60 | +0.27 | +8.1% | $3.33 | $3.60 | $3.225 | 7,800 | |
| $3.33 | +0.14 | +4.4% | $3.13 | $3.35 | $3.13 | 2,700 | |
| $3.19 | -0.06 | -1.8% | $3.235 | $3.25 | $3.09 | 17,801 | |
| $3.25 | -0.06 | -1.8% | $3.20 | $3.32 | $3.16 | 14,509 | |
| $3.31 | -0.03 | -0.9% | $3.28 | $3.335 | $3.235 | 4,500 | |
| $3.34 | -0.22 | -6.2% | $3.36 | $3.60 | $3.27 | 20,800 | |
| $3.56 | +0.11 | +3.2% | $3.54 | $3.75 | $3.49 | 6,000 | |
| $3.45 | +0.03 | +0.9% | $3.585 | $3.74 | $3.36 | 5,600 | |
| $3.42 | -0.07 | -2.0% | $3.61 | $3.725 | $3.42 | 16,200 | |
| $3.49 | +0.129 | +3.8% | $3.44 | $3.68 | $3.36 | 10,100 | |
| $3.361 | -0.159 | -4.5% | $3.48 | $3.63 | $3.15 | 9,700 |
- Ticker
- NASDAQ:NCEL
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Sep 28, 2026
NewCelX Management to Attend Breakthrough T1D Congress in Philadelphia, Advancing Its Mission to Develop a Cure for Type 1 Diabetes
Latest deck · Apr 20, 2026
Investor Presentation (April 2026)
Investor deck · 27 slides
Latest news
NewCelX Management to Attend Breakthrough T1D Congress in Philadelphia, Advancing Its Mission to Develop a Cure for Type 1 Diabetes
Sep 28, 2026
Closed $2.92 (-0.9%) on Sep 28, 2026
NewcelX Announces Pricing of $1.4 Million Equity Financing at 20% Premium Pricing
Jul 31, 2026
Closed $3.49 (+3.8%) on Jul 31, 2026
NewcelX Appoints World-Renowned Diabetes Cure-Focused Pioneer, Dr. Camillo Ricordi, to Scientific Advisory Board
Jul 8, 2026
Closed $4.23 (+5.5%) on Jul 8, 2026
NewcelX Publishes Peer-Reviewed Study Demonstrating Broad Therapeutic Potential of its Stem Cell Technology Platform
Jun 15, 2026
Closed $3.20 (-0.9%) on Jun 15, 2026
NewCelX Ltd. Submits Pre-IND Package to the FDA for NCEL-101 for the Treatment of Type 1 Diabetes
May 27, 2026
Closed $3.45 (+9.5%) on May 27, 2026
NewcelX Reports Financial Results for 2025 and Provides Shareholders with Update on Accelerated Development of Type 1 Diabetes Treatment in Collaboration with Eledon Pharmaceuticals in 2026
Apr 30, 2026
Closed $4.41 (+28.9%) on Apr 30, 2026
NewcelX Updates Corporate Presentation to Highlight Type 1 Diabetes Flagship Program Following Strategic Collaboration with Eledon Pharmaceuticals Ahead of Swiss Biotech Conference
Apr 20, 2026
Closed $2.83 (+6.4%) on Apr 20, 2026
NewcelX Announces Pricing of $1.35 Million Equity Financing at 30% Premium Pricing
Apr 1, 2026
Closed $2.35 (+10.8%) on Apr 1, 2026
NewcelX Announces Strategic Collaboration with Eledon Pharmaceuticals to Advance NCEL-101 Program for Type 1 Diabetes
Mar 9, 2026
Closed $2.74 (-1.1%) on Mar 9, 2026
NewcelX Reports Peer-Reviewed Publication Supporting Mazindol IR/SR and Advances CVR Monetization Strategy
Feb 12, 2026
Closed $2.79 (+1.1%) on Feb 12, 2026
Decks
Investor Presentation (April 2026)
Investor deck · 27 slides · Apr 20, 2026
Investor Presentation (January 2026)
Investor deck · 27 slides · Jan 29, 2026
Investor Presentation (November 2025)
Investor deck · 43 slides · Nov 3, 2025
NLS Pharmaceutics — Investor Presentation (September 2023)
Investor deck · 49 slides · Sep 13, 2023
NewcelX Ltd. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 18 in the last 12 months · 19 in all · newest Sep 28, 2026 · oldest 2025
- Decks
- 9 decks · latest Apr 20, 2026
Where NewcelX Ltd. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:NCEL · Home listing · This page | NASDAQ | United States | USD |
| BOATS:NCEL | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about NewcelX Ltd.